| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| ADC Therapeutics SA (ADCT) | Morgan Stanley/ BofA Merrill Lynch/ Cowen | $150.00 | n.a. | |||
| Aprea Therapeutics (APRE) | J.P. Morgan/ Morgan Stanley/ RBC Capital Markets | $86.25 | n.a. | |||
| Frequency Therapeutics (FREQ) | J.P. Morgan/ Goldman Sachs/ Cowen | $100.00 | n.a. | |||
| Huize Holding Ltd. (HUIZ) | Morgan Stanley/ Citigroup/ CICC | $150.00 | n.a. | |||
| MetroCity Bankshares (MCBS) | Keefe, Bruyette & Woods (A Stifel Company)/ Raymond James | $40.00 | n.a. | |||
| Vir Biotechnology (VIR) | Goldman Sachs/ J.P. Morgan/ Cowen/ Barclays | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Dermavant Sciences (DRMT) | Jefferies/ SVB Leerink/ Guggenheim Securities | 7.70 | $12.00 | $14.00 | $100.10 | n.a. |
| None | ||||||
| New Terms | ||||||
| 10x Genomics (TXG) | J.P. Morgan/ Goldman Sachs/ BofA Merrill Lynch | 9.00 | $31.00 | $35.00 | $297.00 | S/O |
| Alerus Financial (ALRS) | RAYMOND JAMES/ D.A. Davidson & Co. | 3.25 | $22.00 | $24.00 | $74.75 | S/O |
| Cloudflare (NET) | Goldman Sachs/ Morgan Stanley/ J.P. Morgan | 35.00 | $10.00 | $12.00 | $385.00 | S/O |
| Envista Holdings (NVST) | J.P. Morgan/ Goldman Sachs/ Morgan Stanley | 26.77 | $21.00 | $24.00 | $602.28 | S/O |
| IGM Biosciences (IGMS) | Jefferies/ Piper Jaffray/ Stifel/ Guggenheim Securities | 7.81 | $15.00 | $17.00 | $125.00 | S/O |
| LMP Automotive Holdings (LMPX) | ThinkEquity (a division of Fordham Financial Management) | 3.23 | $5.00 | $6.00 | $17.75 | S/O |
| New Providence Acquisition (NPAU) (u) | BTIG | 20.00 | $10.00 | $10.00 | $200.00 | S/O |
| Satsuma Pharmaceuticals (STSA) | Credit Suisse/ SVB Leerink/ Evercore | 5.00 | $14.00 | $16.00 | $75.00 | S/O |
| SmileDirectClub (SDC) | J.P. Morgan/ Citigroup/ BofA Merrill Lynch/ Jefferies/ UBS Investment Bank/ Credit Suisse | 58.54 | $19.00 | $22.00 | $1,200.01 | S/O |
| SpringWorks Therapeutics (SWTX) | J.P. Morgan/ Goldman Sachs/ Cowen | 7.35 | $16.00 | $18.00 | $125.00 | S/O |
| S/O (Subscribers Only) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Sept. 2, 2019 | Manager(s) | Offered | Raised | Price | 9/6/19 | Change |
| None | ||||||
